Lonza Group AG/€LONN
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Lonza Group AG
Lonza Group AG is a global company specializing in pharmaceutical, biotech, and nutrition sectors, headquartered in Basel, Switzerland. It provides integrated solutions for the creation of new drugs, ranging from active pharmaceutical ingredients (APIs) and drug formulation to drug delivery systems. The company serves a diverse clientele including pharmaceutical and biotech companies, offering contract development and manufacturing organization (CDMO) services. With operations in multiple countries, Lonza is strategically positioned to cater to global healthcare needs. Known for its extensive capabilities in cell and gene therapy, the organization leverages advanced technology platforms to support complex biopharmaceutical developments, enhancing its competitive edge in the industry.
Ticker
€LONN
Sector
Primary listing
XGAT
Employees
19,771
Headquarters
Basel, Switzerland
Website
Lonza Group AG Metrics
BasicAdvanced
€39B
37.53
€14.95
0.96
€4.28
0.38%
Price and volume
Market cap
€39B
Beta
0.96
52-week high
€650.16
52-week low
€499.00
Average daily volume
170
Dividend rate
€4.28
Financial strength
Current ratio
2.24
Quick ratio
0.701
Long term debt to equity
42.19
Total debt to equity
45.553
Dividend payout ratio (TTM)
29.50%
Interest coverage (TTM)
8.28%
Profitability
EBITDA (TTM)
2,245.941
Gross margin (TTM)
35.97%
Net profit margin (TTM)
14.53%
Operating margin (TTM)
21.16%
Effective tax rate (TTM)
17.44%
Revenue per employee (TTM)
€365,280
Management effectiveness
Return on assets (TTM)
4.46%
Return on equity (TTM)
9.79%
Valuation
Price to earnings (TTM)
37.527
Price to revenue (TTM)
5.437
Price to book
3.82
Price to tangible book (TTM)
5.1
Price to free cash flow (TTM)
-319.894
Free cash flow yield (TTM)
-0.31%
Free cash flow per share (TTM)
-1.754
Dividend yield (TTM)
0.76%
Forward dividend yield
0.38%
Growth
Revenue change (TTM)
-0.65%
Earnings per share change (TTM)
51.46%
3-year revenue growth (CAGR)
1.62%
10-year revenue growth (CAGR)
5.56%
3-year earnings per share growth (CAGR)
-6.14%
10-year earnings per share growth (CAGR)
9.89%
3-year dividend per share growth (CAGR)
12.62%
10-year dividend per share growth (CAGR)
7.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Lonza Group AG stock?
Lonza Group AG (LONN) has a market cap of €39B as of March 10, 2026.
What is the P/E ratio for Lonza Group AG stock?
The price to earnings (P/E) ratio for Lonza Group AG (LONN) stock is 37.53 as of March 10, 2026.
Does Lonza Group AG stock pay dividends?
Yes, the Lonza Group AG (LONN) stock pays dividends to shareholders. As of March 10, 2026, the dividend rate is €4.28155 and the yield is 0.38%. Lonza Group AG has a payout ratio of 29.5% on a trailing twelve-month basis.
When is the next Lonza Group AG dividend payment date?
The next Lonza Group AG (LONN) dividend payment date is unconfirmed.
What is the beta indicator for Lonza Group AG?
Lonza Group AG (LONN) has a beta rating of 0.96. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.